Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
Status:
Recruiting
Trial end date:
2025-12-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether combination of donepezil, a cholinesterase
inhibitor, with choline alfoscerate has a more favourable clinical profile than monotherapy
with donepezil alone.